A potential antiviral drug for the coronavirus has flopped in its first randomised clinical trial, disappointing scientists and investors who had high hopes for remdesivir, according to draft documents published accidentally by the World Health Organization and seen by the Financial Times.
根據世界衛生組織(WHO)意外發布、英國《金融時報》看到的文件草稿，一種潛在的抗新型冠狀病毒藥物在首項隨機臨床試驗中失敗，令曾經對瑞德西韋(remdesivir)寄予厚望的科學家和投資者失望。
您已閱讀10%（386字），剩余90%（3656字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。